$PLX

$2.53 +$0.05 (2.02%) Close

$PLX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 80.6M shares outstanding

Who owns PLX?

By type of holder

Institutions 17.9% Insiders 6.9% Everyone else 75.2%

Concentration Top 10 holders own 18.0%

BlackRock, Inc. 5.0% · Bashan Dror 3.1%

Institutional ownership

17.9%

-3.0 pts vs last qtr

Institutional holders

100

0 vs last qtr

Net shares bought

−2.4M

by institutions in Q2 2026

New / sold out

18 / 18

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Marshall Wace, LLP NEW +452.8K
BlackRock, Inc. +429.7K

Biggest sellers in Q2 2026

Mak Capital One LLC SOLD OUT −3.5M
Prospera Financial Services Inc SOLD OUT −418.6K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Protalix BioTherapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2019–FY2025

+429.4%

+32.02% a year

Each share's claim on the business

−81.1%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $17.4M

over 7 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years30% 3–5 years20% 1–3 years31% Under 1 year19%

Quarterly turnover

27.1%

of institutional shares changed hands

Top 10 managers, median time held

1.8 years

Super Investors

Investment managers reporting PLX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	4.0M	5.02%	+429.7K (+11.9%)	≤2021	0.0%
Shares held by quarter Peak holding4.0M (Q2'26) Change over 8 quarters+3.9M Share of the company5.020% BlackRock, Inc.'s full portfolio →
MC Mak Capital One LLC	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding3.5M (Q1'26) Change over 8 quarters0 Mak Capital One LLC's full portfolio →

BlackRock, Inc.

4.0M

% of company

5.02%

Change vs last qtr

+429.7K (+11.9%)

Held since

≤2021

Mak Capital One LLC

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

28 more super investors behind a free account

See every manager holding Protalix BioTherapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting PLX on Form N-PORT; together they hold 7.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IR iShares Russell 2000 ETF iShares Trust	$4.5M	1.9M	2.40%	0.01%	June 30, 2026
FS Fidelity Small Cap Index Fund Fidelity Salem Street Trust	$1.9M	802.5K	1.00%	0.01%	July 31, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$4.5M

% of company

2.40%

% of the fund

0.01%

As of

June 30, 2026

Fidelity Small Cap Index Fund

Fidelity Salem Street Trust

Position value

$1.9M

% of company

1.00%

% of the fund

0.01%

As of

July 31, 2026

23 more funds behind a free account

See every fund holding Protalix BioTherapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
BD Bashan Dror Insider	2.5M	3.14%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company3.140% Bashan Dror's insider activity →
BA Bar-Shalev Amos Insider	2.5M	3.08%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company3.080% Bar-Shalev Amos's insider activity →

Bashan Dror

Insider

2.5M

% of company

3.14%

Change vs last qtr

—

Held since

—

Bar-Shalev Amos

Insider

2.5M

% of company

3.08%

Change vs last qtr

—

Held since

—

8 more holders behind a free account

See every insider and 5%+ holder of Protalix BioTherapeutics, Inc..

Comments